Genetic abnormalities in marginal zone B-cell lymphoma

Hematological Oncology

Volumn 18, Issue 1, 2000, Pages 1-13

  Dierlamm, Judith ^a   Wlodarska, Iwona ^b   Michaux, Lucienne ^b   Stefanova, Margarita ^a   Hinz, Kristina ^a   Van Den Berghe, Herman ^b   Hagemeijer, Anne ^b   Hossfeld, Dieter Kurt ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

BCL10; FAS; MALT lymphoma; Marginal zone B cell lymphoma; MLT; T(11; 18); t(1; 14); Trisomy 3

Indexed keywords

B CELL LYMPHOMA; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; GENE MUTATION; HUMAN; IMMUNOGLOBULIN GENE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TRISOMY;

EID: 0034121924     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(200003)18:1<1::AID-HON647>3.0.CO;2-G     Document Type: Review

References (68)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
2. De Wolf-Peeters C, Pittaluga S, Dierlamm J, Wlodarska I, Van den Berghe H. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma, and splenic marginal zone cell lymphomas and their relation to the reactive marginal zone. Invited Review. Leuk Lymph 1997; 26: 467-478.
3. Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410-1416.
4. Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H. Monocytoid B-cell lymphoma: a novel B-cell neoplasm. Am J Pathol 1986; 124: 310-318.
5. Schmid C, Kirkham N, Diss T, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992; 16: 455-466.
6. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996; 178: 122-127.
7. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
8. Nizze H, Cogliatti SB, Von Schilling C, Feller AC, Lennert K. Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology 1991; 18: 403-414.
9. Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES. Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 1999; 23: 59-68.
10. Pittaluga S, Verhoef G, Criel A, et al. 'Small' B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry and cytogenetic analysis. Am J Surg Pathol 1996; 20: 211-223.
11. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood 1994; 84: 3828-3834.
12. Hammer RD, Glick AD, Greer JP, Collins RD, Cousar JB. Splenic marginal zone lymphoma. A distinct B-cell neoplasm. Am J Surg Pathol 1996; 20: 613-626.
13. Mulligan SP, Matutes E, Dearden C, Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 1991; 78: 206-209.
14. MacLennan ICM, Liu YL, Oldfield S, Zhang J, Lane PJL. The evolution of B cell clones. Curr Top Microbiol Immunol 1990; 159: 37-63.
15. Qin Y, Greiner A, Trunk JF, Schmausser B, Ott MM, Müller-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue type B-cell lymphoma. Blood 1995; 86: 3528-3534.
16. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin genes suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996; 10: 1190-1197.
17. Tierens A, Delabie J, Pittaluga S, Driessen A, De Wolf-Peeters C. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 1998; 91: 2381-2386.
18. Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf-Peeters C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999; 93: 226-234.
19. Clark HM, Jones DB, Wright DH. Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol 1992; 166: 129-137.
20. Horsman D, Gascoyne R, Klasa R, Coupland R. t(11;18)(q21;q21.1). A recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)? Genes Chromosom Cancer 1992; 4: 183-187.
21. Robledo M, Benitez J, Rivas C. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1992; 62: 208-209.
22. Wotherspoon AC, Pan L, Diss TC, Isaacson PG. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1992; 58: 35-38.
23. Whang-Peng J, Knutsen T, Jaffe E, et al. Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1994; 77: 74-80.
24. Kubonishi I, Sugito S, Kobayashi M, et al. A unique chromosome translocation, t(11;12;18)(q13;q13;q12), in primary lung lymphoma. Cancer Genet Cytogenet 1995; 82: 54-56.
25. Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphological features. Blood 1996; 87: 299-307.
26. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997; 8: 979-985.
27. Dierlamm J, Pittaluga S, Stul M, et al. BCL6 gene rearrangements occur also in marginal zone B-cell lymphoma. Br J Haematol 1997; 98: 719-725.
28. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT) type. Cancer Res 1997; 57: 3944-3947.
29. Akagi T, Tamura A, Motegi M, et al. Molecular cytogenetic delineation of the breakpoint at 18q21.1 in low-grade B-cell lymphoma of mucosa associated lymphoid tissue. Genes Chromosom Cancer 1999; 24: 315-321.
30. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with MALT lymphomas. Blood 1999; 93: 3601-3609.
31. Hosaka S, Akamutsu T, Nakamura S, et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the rectum with chromosomal translocation t(11;18)(q21;q21) and an additional aberration of trisomy 3. Am J Gastroenterol 1999; 94: 1951-1954.
32. Stoffel A, Rao PH, Louie DC, et al. Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC. Genes Chromosom Cancer 1999; 24: 156-159.
33. Willis TG, Jadayel DM, Du M-Q, et al. BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35-45.
34. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nature Genet 1999; 22: 63-68.
35. Levine EG, Arthur DC, Machnicki J, et al. Four new recurring translocations in non-Hodgkin lymphoma. Blood 1989; 74: 1796-1800.
36. Griffin CA, Zehnbauer BA, Beschorner WE, Ambinder R, Mann R. t(11;18)(q21;q21) is a recurrent chromosome abnormality in small lymphocytic lymphoma. Genes Chromosom Cancer 1992; 4: 153-157.
37. Leroux D, Seité P, Hillion J, et al. t(11;18)(q21;q21) may delineate a spectrum of diffuse small B-cell lymphoma with extranodal involvement. Genes Chromosom Cancer 1993; 7: 54-56.
38. Banerjee SS, Harris M, Eyden BP, Radford JA, Harrison CJ, Mainwaring AR. Monocytoid B cell lymphoma. J Clin Pathol 1991; 44: 39-44.
39. Slovak ML, Weiss LM, Nathwani BN, Bernstein L, Levine A. Cytogenetic study of composite lymphoma: Monocytoid B-cell lymphoma and other B-cell non-Hodgkin's lymphoma. Hum Pathol 1993; 24: 1086-1094.
40. Dierlamm J, Rosenberg C, Stul M, et al. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 1997; 11: 747-758.
41. Dierlamm J, Michaux L, Wlodarska I, et al. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization. Br J Haematol 1996; 93: 242-249.
42. Wotherspoon AC, Pan L, Diss TC, Isaacson PG. A genotypic study of low-grade B-cell lymphomas, including lymphomas of mucosa-associated lymphoid tissue (MALT). J Pathol 1990; 162: 135-140.
43. Van Krieken JHJM, Raffeld M, Raghoebier S, Jaffe ES, van Ommen GJB, Kluin PhM. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797-800.
44. Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphomas. Blood 1995; 86: 4587-4593.
45. Neumeister P, Hoefler G, Beham-Schmid C, et al. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 1997; 112: 1871-1875.
46. Dierlamm J, Stefanova M, Wlodarska I, et al. Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase FISH study. Cancer Genet Cytogenet 1999; in press.
47. Oscier DG, Matutes E, Gardiner A, et al. Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 1993; 85: 487-491.
48. Troussard X, Mauvieux L, Radford-Weiss I, et al. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d'Hématologie Cellulaires (CFHC) study. Br J Haematol 1998; 101: 712-721.
49. García-Marco JA, Nouel A, Navarro B, et al. Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RBI gene but not the D13S25 locus on chromosome 13q14. Cancer Res 1998; 58: 1736-1740.
50. Mateo M, Mollejo M, Villuendas R, et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999; 154: 1583-1589.
51. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa associated lymphoid tissue. Blood 1995; 85: 2000-2004.
52. Brynes RK, Almaguer PD, Leathery KE, et al. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod Pathol 1996; 9: 995-1000.
53. Zhang Y, Cheung ANY, Chan ACL, et al. Detection of trisomy 3 in primary gastric B-cell lymphoma by using chromosome in situ hybridization on paraffin sections. Am J Clin Pathol 1998; 110: 347-353.
54. Blanco R, Lydia M, Davis B, Kraus M, Fenoglio-Preiser C. Trisomy 3 in gastric lymphomas of extranodal marginal zone B-cell (mucosa associated lymphoid tissue) origin demonstrated by FISH on intact paraffin sections. Hum Pathol 1999; 30: 706-711.
55. Ott G, Kalla J, Steinhoff A, et al. Trisomy 3 is not a common feature in malignant lymphomas of the mucosa-associated lymphoid tissue type. Am J Pathol 1998; 153: 689-694.
56. Sole F, Woessner S, Florensa L, et al. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol 1997; 98: 446-449.
57. Starostik P, Greiner A, Schulz A, Zettl A, Kolve M, Müller-Hermelink HK. Tumor suppressor pathway plays a major role in the pathogenesis of gastric high-grade MALT lymphoma. Blood 1998; 92(Suppl. 1): 222a.
58. Mitelman F. Catalog of Chromosome Aberrations in Cancer (5th edn), Wiley-Liss: New York, 1994
59. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogens 1999; 18: 5785-5794.
60. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitor of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-3259.
61. Du M, Singh N, Husseuin A, Isaacson PG, Pan L. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT). J Pathol 1996; 178: 379-384.
62. Greiner A, Seeberger H, Knörr C, Starostik P, Müller-Hermelinck HK. MALT-type B-cell lymphomas escape the censoring FAS-mediated apoptosis. Blood 1998; 92(Suppl. 1): 484a.
63. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914-6925.
64. Hay BA, Wassarman DA, Rubin GM. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell 1995; 83: 1253-1262.
65. Hofmann K, Bucher P, Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sd 1997; 22: 155-156.
66. Fakruddin JM, Chaganti RSK, Murty VVVS. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell 1999; 97: 683-684.
67. Apostolou S, De Rienzo A, Murthy SS, Jhanwar SC, Testa JR. Absence of BCL10 mutations in human mesothelioma. Cell 1999; 97: 684-686.
68. Gronbaek K, Straten P, Ralfkiaer E, et al. Somatic FAS mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998; 92: 3018-3024.